Literature DB >> 21531745

Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.

T Suzuki1, O Kitajima, K Ueda, Y Kondo, J Kato, S Ogawa.   

Abstract

BACKGROUND: This study compared the reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
METHODS: Fifteen younger (20-50 yr) and 15 older (≥70 yr) patients were sequentially enrolled in this study. After induction of anaesthesia and laryngeal mask insertion, contraction of the adductor pollicis muscle in response to ulnar nerve stimulation was quantified using acceleromyography during 1.0-1.5% end-tidal sevoflurane and remifentanil anaesthesia. All patients initially received rocuronium 1 mg kg(-1), followed by 0.02 mg kg(-1) when a post-tetanic count (PTC) of 1 or 2 was observed. After completion of surgery, at reappearance of 1-2 PTC, the time required for a single bolus dose of 4 mg kg(-1) sugammadex to produce recovery to a train-of-four (TOF) ratio of 0.9 was recorded.
RESULTS: There were no differences in the total dose of rocuronium administered between the younger [mean (sd): 93.4 (17.5) mg] and the older [97.5 (32.2) mg] groups. In all patients, adequate recovery of the TOF ratio to 0.9 was achieved after administration of sugammadex, although it was significantly slower in the older [3.6 (0.7) min, P<0.0001] than in the younger group [1.3 (0.3) min]. There were no clinical events attributable to recurarization.
CONCLUSIONS: Sugammadex can adequately restore neuromuscular function in older patients, although a longer time is required to recover from profound rocuronium-induced neuromuscular block than in younger patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531745     DOI: 10.1093/bja/aer098

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Efficacy of different doses of sugammadex after continuous infusion of rocuronium.

Authors:  Diego Soto Mesa; Mounir Fayad Fayad; Laura Pérez Arviza; Verónica Del Valle Ruiz; Fernando Cosío Carreño; Luis Arguelles Tamargo; Manuel Amorín Díaz; Sergio Fernández-Pello Montes
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

2.  Effects of cardiac output on the onset of rocuronium-induced neuromuscular block in elderly patients.

Authors:  Naoki Shiraishi; Mayu Aono; Yasuhito Kameyama; Mai Yamamoto; Osamu Kitajima; Takahiro Suzuki
Journal:  J Anesth       Date:  2018-05-21       Impact factor: 2.078

3.  A Comparision of the Effect of Sugammadex on the Recovery Period and Postoperative Residual Block in Young Elderly and Middle-Aged Elderly Patients.

Authors:  Emine Yazar; Canan Yılmaz; Hülya Bilgin; Derya Karasu; Selcan Bayraktar; Yılmaz Apaydın; Halil Erkan Sayan
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

4.  Efficiency of the TOF-Cuff™ for the evaluation of rocuronium-induced neuromuscular block and its reversal with sugammadex: a comparative study vs. acceleromyography.

Authors:  Yasuhito Kameyama; Shunichi Takagi; Katsuhisa Seto; Ichie Kajiwara; Miori Goto; Osamu Kitajima; Takahiro Suzuki
Journal:  J Anesth       Date:  2018-11-24       Impact factor: 2.078

5.  Sugammadex rescue following prolonged rocuronium neuromuscular blockade with 'recurarisation' in a patient with severe renal failure.

Authors:  Steven Lobaz; Mario Sammut; Anand Damodaran
Journal:  BMJ Case Rep       Date:  2013-02-07

6.  Anesthesia for flap surgery in a patient with polymyositis.

Authors:  Sowoon Ahn; Ju Ho Lee; Eun Ah Yang; Chunghyun Park; Dong Wook Shin
Journal:  Korean J Anesthesiol       Date:  2014-12

7.  The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex.

Authors:  Hee Jong Lee; Kyo Sang Kim; Ji Seon Jeong; Kyu Nam Kim; Byeong Chan Lee
Journal:  BMC Anesthesiol       Date:  2015-01-21       Impact factor: 2.217

8.  Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.

Authors:  Katja Rezonja; Tomaz Mars; Ales Jerin; Gordana Kozelj; Neva Pozar-Lukanovic; Maja Sostaric
Journal:  BMC Anesthesiol       Date:  2016-10-21       Impact factor: 2.217

Review 9.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

Review 10.  Neuromuscular blockade in the elderly patient.

Authors:  Luis A Lee; Vassilis Athanassoglou; Jaideep J Pandit
Journal:  J Pain Res       Date:  2016-06-17       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.